# Caris Life Sciences (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/caris-life-sciences-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.8 |
| Citations | 94,362 |
| City | Irving |
| Country | US |
| Description | Caris Life Sciences (United States) is a research organisation in Irving, US. OpenAlex records 1,841 works and 94,362 citations for it. 553 researchers list it as their most recent affiliation. |
| Homepage | https://www.carislifesciences.com/ |
| OpenAlex ID | https://openalex.org/I4210140103 |
| Region | Texas |
| Researchers | 553 |
| ROR ID | https://ror.org/04wh5hg83 |
| Type | company |
| Works | 1,841 |

## University papers

- [Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade](https://scholariq.org/papers/mismatch-repair-deficiency-predicts-response-of-solid-tumors-to-pd-1-blockade/)
- [Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients](https://scholariq.org/papers/mutational-landscape-of-metastatic-cancer-revealed-from-prospective-clinical/)
- [Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children](https://scholariq.org/papers/efficacy-of-larotrectinib-in-i-trk-i-fusion-positive-cancers-in-adults-and/)
- [Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)](https://scholariq.org/papers/memorial-sloan-kettering-integrated-mutation-profiling-of-actionable-cancer/)
- [Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial](https://scholariq.org/papers/prognostic-and-predictive-value-of-the-21-gene-recurrence-score-assay-in/)
- [Integrated digital error suppression for improved detection of circulating tumor DNA](https://scholariq.org/papers/integrated-digital-error-suppression-for-improved-detection-of-circulating-tumor/)
- [Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100](https://scholariq.org/papers/association-of-vascular-endothelial-growth-factor-and-vascular-endothelial/)
- [ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper](https://scholariq.org/papers/ctdna-applications-and-integration-in-colorectal-cancer-an-nci-colon-and-rectal/)
- [進行性乳癌のためのESO-ESMO国際コンセンサスガイドライン第四版(ABC 4)](https://scholariq.org/papers/eso-esmo-abc-4/)

## University top topics

Showing 8 of 25.

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.